Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinomaDavid A. Braun, Toni K. Choueiri, Megan Wind‐Rotolo et al.|Nature Medicine|2020Cited by 1k
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical TrialJean‐Christophe Pignon, Sabina Signoretti, Opeyemi A. Jegede et al.|Clinical Cancer Research|2019Cited by 121
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell CarcinomaMiriam Ficial, Sabina Signoretti, Opeyemi A. Jegede et al.|Clinical Cancer Research|2020Cited by 81
Table S1 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaDavid J. Kwiatkowski, Sabina Signoretti, Toni K. Choueiri et al.|Unknown|2023Cited by 0
Table S1 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaDavid J. Kwiatkowski, Sabina Signoretti, Toni K. Choueiri et al.|Unknown|2023Cited by 0